Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Evidence that modafinil blocks the brain dopamine transporter and decreases dopamine D2 receptor availability in humans

Joanna Fowler, N. Volkow, G. Wang, F. Telang and J. Logan
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 38P;
Joanna Fowler
1Brookhaven National Laboratory, Upton, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Volkow
2NIDA, Bethesda, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Wang
1Brookhaven National Laboratory, Upton, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Telang
3NIAAA, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Logan
1Brookhaven National Laboratory, Upton, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 49 no. supplement 1 38P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Joanna Fowler1,
  2. N. Volkow2,
  3. G. Wang1,
  4. F. Telang3 and
  5. J. Logan1
  1. 1Brookhaven National Laboratory, Upton, New York;
  2. 2NIDA, Bethesda, Maryland;
  3. 3NIAAA, Bethesda, Maryland

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2015 to April 2025

AbstractFullPdf
Mar 2015300
Jul 2015200
Sep 2015400
Apr 2016200
May 2016100
Jul 2016100
Sep 2016100
Nov 2016100
Jan 2017100
Feb 2017200
May 2017100
Jun 2017200
Sep 2017100
Dec 2017200
Feb 2018200
Mar 2018100
May 2018200
Sep 2018100
Oct 2018100
Nov 2018100
Dec 2018400
Jan 2019400
Feb 2019500
Mar 2019700
Apr 2019800
May 2019400
Jun 20191100
Jul 20191800
Aug 20191100
Sep 20191700
Oct 20193300
Nov 20191900
Dec 20191800
Jan 20201700
Feb 20202600
Mar 20202300
Apr 20202200
May 20204600
Jun 20202000
Jul 20201300
Aug 20201600
Sep 20201900
Oct 2020900
Nov 20201600
Dec 20201400
Jan 2021600
Feb 20211800
Mar 20212000
Apr 20211200
May 20211900
Jun 20211600
Jul 20211400
Aug 20211600
Sep 20212400
Oct 20212800
Nov 20212200
Dec 20211900
Jan 20223300
Feb 20221800
Mar 20222900
Apr 20222600
May 20223100
Jun 20223100
Jul 20222700
Aug 20221600
Sep 20222700
Oct 20222100
Nov 20223900
Dec 20224100
Jan 20233000
Feb 20234800
Mar 20233600
Apr 20233300
May 20234200
Jun 20234200
Jul 20235900
Aug 20235900
Sep 20233500
Oct 20234600
Nov 20234000
Dec 20233400
Jan 20243700
Feb 20243900
Mar 20244500
Apr 20246300
May 20246500
Jun 20246700
Jul 20246700
Aug 20247600
Sep 202411200
Oct 20246500
Nov 20245900
Dec 20249100
Jan 20257900
Feb 20258100
Mar 20255800
Apr 202529800
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 49, Issue supplement 1
May 1, 2008
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evidence that modafinil blocks the brain dopamine transporter and decreases dopamine D2 receptor availability in humans
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evidence that modafinil blocks the brain dopamine transporter and decreases dopamine D2 receptor availability in humans
Joanna Fowler, N. Volkow, G. Wang, F. Telang, J. Logan
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 38P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evidence that modafinil blocks the brain dopamine transporter and decreases dopamine D2 receptor availability in humans
Joanna Fowler, N. Volkow, G. Wang, F. Telang, J. Logan
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 38P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Brain glucose metabolism changes following thyroid function normalization in hyperthyroidism
  • Thalamic glucose metabolism matched with ultra high resolution anatomy and tractography obtained by PET-MRI fusion imaging
  • Shape analysis method can be used for limited non-invasive estimation of striatal and cerebellar [11C]-PMP k3 hydrolysis rates
Show more Neurosciences: Psychiatry

Dopamine Disorders and Treatment

  • Methamphetamine pharmacokinetics in human brain: Comparison with cocaine
  • Quetiapine has a D2/3 receptor binding profile similar to clozapine: A [18F]fallypride PET study in patients with schizophrenia
  • Striatal and extrastriatal D2/3-receptor binding of ziprasidone: Implications of different study schedules
Show more Dopamine Disorders and Treatment

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire